MEDNAX Forges Alliance For Better Health Services In Texas
Zacks Investment Research | Jun 17, 2019 03:21AM ET
MEDNAX, Inc. (NYSE:MD) recently announced an affiliation with Alfredo Gei MD, P.A., a private maternal-fetal medicine practice located in Houston. However, terms of this cash transaction were not disclosed.
With this deal, MEDNAX would be able to ramp up the services it provides at Texas via its network of affiliated physicians in multiple specialties, such as newborn hearing screen, neonatology, developmental pediatrics, maternal-fetal medicine, obstetric hospitalist, pediatric critical care, pediatric hospitalist, pediatric ophthalmology, pediatric otolaryngology, anesthesiology and radiology et al. This collaboration is expected to be immediately accretive to its earnings.
Notably, Alfredo Gei MD would be able to gain traction from MEDNAX’s national network, which is necessary for the team to be consistent in growth and provide advanced care to patients. Management believes that MEDNAX’s nationally acclaimed research and initiatives will strengthen Alfredo Gei MD’s practice, render improved patient services and give it a chance to add value to its hospital partners.
The company’s allied physician practices deliver exceptional perinatal care in Houston and its physician network caters to maternal-fetal medicine services to 12 area hospital partners.
MEDNAX has been constantly making efforts to boost its portfolio over the last few quarters. In March, it announced its affiliation to Georgia Neonatology, LLC, a private neonatology practice located in Athens, GA. This agreement added to MEDNAX’s wide array of services in Georgia via its network of associated physicians across various specialties including pain management, anesthesiology, maternal-fetal medicine, neonatology, newborn hearing screen, obstetric hospitalist, pediatric hospitalist and radiology.
Last month, the company declared its affiliation with Central Coast Perinatal Medical Group, Inc., with which it was able to drive its services in California through its affiliated network of physicians ranging over various multiple specialties, including maternal-fetal medicine, neonatology, newborn hearing screen, obstetric hospitalist, pediatric cardiology, pediatric critical care, pediatric hospitalist and radiology.
MEDNAX has always been active when it comes to catalyzing its inorganic growth profile. Apart from several tie-ups, the company has acquired several organizations to enrich its capabilities. During 2018, it acquired nine physician group practices including five radiology, two neonatology and two pediatric subspecialty practices. The company expects to close several purchases in women and children services in the upcoming quarters. We believe, all these strategic initiatives bode well for the company’s growth.
Get The News You Want
Shares of this Zacks Rank #4 (Sell) company have plunged 42.9% in a year’s time against its ’s growth of 5.3%. what can rebound the shares.
Key Picks
Investors interested in the medical sector can take a look at some better-ranked stocks like WellCare Health Plans, Inc. (NYSE:WCG) , HCA Healthcare, Inc. (NYSE:HCA) and Molina Healthcare, Inc (NYSE:MOH) . You can see .
WellCare Health offers managed care services to government-sponsored health care programs. The company pulled off average positive surprise of 13.52% in the preceding four quarters. It holds a Zacks Rank #2 (Buy).
HCA Healthcare provides health care services. In the last four quarters, the company delivered average beat of 15.74%. The company carries a Zacks Rank of 2.
Molina Healthcare is a multi-state healthcare organization. In the trailing four quarters, the company came up with average beat of 88.17%. It sports a Zacks Rank #1 (Strong Buy).
Radical New Technology Creates $12.3 Trillion Opportunity
Imagine buying Microsoft (NASDAQ:MSFT) stock in the early days of personal computers… or Motorola (NYSE:MSI) after it released the world’s first cell phone. These technologies changed our lives and created massive profits for investors.
Today, we’re on the brink of the next quantum leap in technology. 7 innovative companies are leading this “4th Industrial Revolution” - and early investors stand to earn the biggest profits.
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.